Abstract
Motor complications observed in patients with advanced Parkinson's disease (PD) on oral medications might be due to impaired gastric emptying and fluctuating drug plasma levels. A novel treatment for PD involves the use of a percutaneous endoscopic gastrostomy with jejunal extension tube (PEG-J) to provide continuous delivery of levodopa-carbidopa intestinal gel (LCIG) directly to the jejunum.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
